US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk

1

By Jonathan Stempel Oct 26 (Reuters) – A US judge rejected on Monday Novo Nordisk's request to block Eli Lilly from continuing advertisements for weight-loss drugs that the Danish drugmaker considered

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)